Population-based study of statins, angiotensin II receptor blockers, and angiotensin-converting enzyme inhibitors on pneumonia-related outcomes. - Wikidata - awgldk - TriplyDB

Population-based study of statins, angiotensin II receptor blockers, and angiotensin-converting enzyme inhibitors on pneumonia-related outcomes.

Population-based study of statins, angiotensin II receptor blockers, and angiotensin-converting enzyme inhibitors on pneumonia-related outcomes.

http://www.wikidata.org/entity/Q36379603

about

Treating the host response to emerging virus diseases: lessons learned from sepsis, pneumonia, influenza and Ebola.Progress of small molecular inhibitors in the development of anti-influenza virus agents.The controversy over H5N1 transmissibility research: an opportunity to define a practical response to a global threat Predictors of rehospitalization after admission for pneumonia in the veterans affairs healthcare system Effect of statin therapy on mortality from infection and sepsis: a meta-analysis of randomized and observational studies.Age-related differences in management and outcomes in hospitalized healthy and well-functioning bacteremic pneumococcal pneumonia patients: a cohort study.Pre-existing atrial fibrillation and risk of arterial thromboembolism and death following pneumonia: a population-based cohort study Treating the Host Response to Ebola Virus Disease with Generic Statins and Angiotensin Receptor Blockers Application of a methicillin-resistant Staphylococcus aureus risk score for community-onset pneumonia patients and outcomes with initial treatment The cytokine storm of severe influenza and development of immunomodulatory therapy The effect of statin therapy on the incidence of infections: a retrospective cohort analysis.Angiotensin-Converting Enzyme Inhibitors and Active Tuberculosis: A Population-Based Study.The association of renin-angiotensin system blockades and pneumonia requiring admission in patients with COPD.Non-invasive mechanical ventilation and mortality in elderly immunocompromised patients hospitalized with pneumonia: a retrospective cohort study.Recurrent pneumonia: a review with focus on clinical epidemiology and modifiable risk factors in elderly patients.Evaluating the Effects of Chronic Antihypertensives on Vasopressor Dosing in Septic Shock.Clinical Management of Community Acquired Pneumonia in the Elderly Patient.Application of a Risk Score to Identify Older Adults with Community-Onset Pneumonia Most Likely to Benefit From Empiric Pseudomonas Therapy.Bacteria and endothelial cells: a toxic relationship.Statin potency and the risk of hospitalization for community-acquired pneumonia.miRNA-200c-3p is crucial in acute respiratory distress syndrome.The High Blood Pressure-Malaria Protection Hypothesis.The effect of statins on influenza-like illness morbidity and mortality.Increased statin prescribing does not lower pneumonia risk.HDL-c levels predict the presence of pleural effusion and the clinical outcome of community-acquired pneumonia.Clinician-initiated research on treating the host response to pandemic influenza.Angiotensin II receptor blocker as a novel therapy in acute lung injury induced by avian influenza A H5N1 virus infection in mouse.The Concomitant Use of Diuretics, Non-Steroidal Anti-Inflammatory Drugs, and Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers (Triple Whammy), Extreme Heat, and In-Hospital Acute Kidney Injury in Older Medical Patients.Statin Use and Hospital Length of Stay Among Adults Hospitalized With Community-acquired Pneumonia.Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPD.Endothelial Activation: The Ang/Tie Axis in Sepsis.Protective Capacity of Statins during Pneumonia Is Dependent on Etiological Agent and Obesity.Do outpatient statins and ACEIs/ARBs have synergistic effects in reducing the risk of pneumonia? A population-based case-control study.Microbial interactions with the intestinal epithelium and beyond: Focusing on immune cell maturation and homeostasis

P2860

Q28076034-D23F5556-9CB3-411E-923C-E1D9EE2BDF6D Q30234943-4ABD16CD-9B87-442C-A973-4660219AFFED Q30426929-5CC9DC4A-BB85-43C6-AD8C-36FBB7205DCC Q33719404-3C2C2E24-A238-4863-A9E5-4BE7D55A0FBB Q33752584-A9A6F1A3-C1B1-4458-87E0-37B8C91AE04D Q33816163-27D792E6-46F9-4883-A458-417C9E0B8C11 Q34573036-E77C35B3-9E5C-4442-9D02-FCB8782035FF Q35777761-44ACE3B8-1543-4C18-9B3A-66F9831C2183 Q35780916-6DB2CF89-3258-42E9-9CEE-5D6AA465B487 Q36459143-62A47E25-CA1B-4F3A-8961-23FBB04F77A7 Q36876210-DC1BC1E0-CBB3-4797-B02F-797566FF9B21 Q36993403-26EB292F-6A73-4F59-A94F-FCA0BB3A8B36 Q37259422-AD963FA8-D8C8-4D0F-B874-20927FDD6786 Q37556732-937165CC-C109-469D-A391-4BAFA188B1AC Q38285835-D173CC7A-A51A-422B-B40B-07BF126C633B Q38629194-DF8BB554-2F67-4FC8-9A4C-0F619EB28C53 Q38969066-B28B3598-76C9-4E99-B155-602B9975A3E8 Q39051283-B27464B9-DF35-41CF-B4F7-DA3751894CFD Q39053084-DF68599C-A2F4-46C1-9ABA-93CCD11DFABA Q39108826-03501454-AED6-46BF-89B9-C54E70E2A04A Q40129965-88EA6246-0BE5-4794-BC29-DCAB0E59C83D Q40509426-4C48BC83-9FC1-482C-97EA-BB5547E3CA71 Q40560139-625E6A9B-203E-421A-8440-1691995415C1 Q41248831-AF214101-01C4-40F0-90BE-89CB64F18C50 Q42499276-CB5A0549-8F81-4C74-84A1-FDDA824B05C8 Q44105968-52F94A97-955E-4E62-8098-C6783C9AE08C Q45343317-4DD6B94B-C46C-43B2-A37C-5A92748FC350 Q47632802-A03AB637-DBE2-4E99-AFB4-99B5F98B5772 Q48055737-8DBD859D-4E76-4D28-9149-1685CFC4A190 Q52643797-7DA9A4E1-57CE-40DF-A495-3E35338B64D8 Q54217602-DC7ADDB8-2AEA-4093-9C49-58AFD639BAE1 Q54263540-4A128236-4587-4BFF-8B57-FA2B4D3BD2AB Q55646010-850BA990-68B2-4C9F-8C90-9AACD0BA5C81 Q57193137-000E7FF1-B912-43A5-8DF9-F724762B648F

P2860

Population-based study of statins, angiotensin II receptor blockers, and angiotensin-converting enzyme inhibitors on pneumonia-related outcomes.

http://www.wikidata.org/entity/Q36379603

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Population-based study of stat ...... on pneumonia-related outcomes.

@ast

Population-based study of stat ...... on pneumonia-related outcomes.

@en

type

label

Population-based study of stat ...... on pneumonia-related outcomes.

@ast

Population-based study of stat ...... on pneumonia-related outcomes.

@en

prefLabel

Population-based study of stat ...... on pneumonia-related outcomes.

@ast

Population-based study of stat ...... on pneumonia-related outcomes.

@en

P1433

Q36379603-C47E8D48-3964-44B3-B7D5-86AF0514E288

P1476

Q36379603-36C1E0FB-CDFB-41E1-A5DD-68C8BB3A515F

P2093

Q36379603-3A1A36BA-043E-4D95-9D61-69AD89D0F3C6

Q36379603-48B923C5-7A4A-4467-9775-1610818CAD5D

Q36379603-54B154CD-0FF0-46E6-A8AA-BB8F2469EBD3

Q36379603-55747D44-0446-4924-9718-D2CDDE6BC01A

Q36379603-8CE520B0-2FCF-48F2-8A9E-AE367E33CF87

Q36379603-AD93555A-6632-4FA3-9B7F-E38D4BEF573E

Q36379603-DC5ABC37-9163-4264-BFB0-7E8814191A75

Q36379603-F2B164F1-E027-4563-A737-91305A63E74C

P2860

Q36379603-0BDB1DC9-9AA1-4E9D-9195-BEDF4CEBEE4F

Q36379603-0E5FDBA1-7500-4212-B6E3-275C8CFFDD0C

Q36379603-18B2A76B-3191-4AFA-8E25-742F81EB86D8

Q36379603-36F03771-BA8A-43A1-B8F9-27914EB84022

Q36379603-3CDC3D47-3CD8-4EC2-A667-51C8A4D0A65E

Q36379603-3EE61328-7EA2-4B0D-9401-6107E879BC04

Q36379603-4C9A04C2-9EFC-48E4-ACD1-7205324670C5

Q36379603-50924300-BB6C-4840-A319-3CAB6B6F4E05

Q36379603-52107D8F-0BA3-44B7-9E1F-DB70E0B82ED0

Q36379603-643B1CE2-D1C5-4004-B038-8F003A6EA616

P304

Q36379603-8271E406-4E51-4B44-8444-FBB628019A8A

P31

Q36379603-238F176A-6728-4593-A2EB-7E7F009BEC50

P356

Q36379603-D01F3938-33AE-4C75-92C1-3919C32B0158

P407

Q36379603-7E641C8E-734D-4B57-BB69-341879674006

P433

Q36379603-C1541DED-81DE-4829-9000-6B17FA578210

P478

Q36379603-C498C401-7315-40CD-BC3B-E4DBFF4DDD03

P50

Q36379603-4F411B72-EAE7-4875-B1B6-216D0DD4B245

Q36379603-57538870-7602-481D-9C9B-B1FF5A2AEEBF

Q36379603-CA9E09A7-1D7E-46A8-BA31-6A7937AF191C

P577

Q36379603-916A9A02-CEE0-4366-B269-482D6191D006

P5875

Q36379603-9904BF33-F5D4-4668-81CA-4443668BE44B

P698

Q36379603-730211AE-A79C-4FE1-8DCB-3992D9EDAC26

P921

Q36379603-A947F58B-00F3-460B-B5A8-6C38D93A16CC

P932

Q36379603-9F48293A-0EF1-4436-A67D-046A65BC63A0

P356

P1433

Clinical Infectious Diseases

P1476

Population-based study of stat ...... on pneumonia-related outcomes

@en

P2093

Antonio Anzueto

http://www.w3.org/2001/XMLSchema#string

Brandy Nakashima

http://www.w3.org/2001/XMLSchema#string

Chester Good

http://www.w3.org/2001/XMLSchema#string

Christopher R Frei

http://www.w3.org/2001/XMLSchema#string

John Cornell

http://www.w3.org/2001/XMLSchema#string

John R Downs

http://www.w3.org/2001/XMLSchema#string

Marcos I Restrepo

http://www.w3.org/2001/XMLSchema#string

Michael J Fine

http://www.w3.org/2001/XMLSchema#string

P2860

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

Atherosclerosis — An Inflammatory Disease

Points of control in inflammation

Accuracy and completeness of mortality data in the Department of Veterans Affairs.

Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels.

The effect of statins on mortality in patients with bacteremia.

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.

Causes of death for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team cohort study.

Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study

Comparison of systemic cytokine levels in patients with acute respiratory distress syndrome, severe pneumonia, and controls.

P304

1466-1473

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CID/CIS733

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P50

Laurel A. Copeland

P577

2012-08-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230733793

http://www.w3.org/2001/XMLSchema#string

P698

22918991

http://www.w3.org/2001/XMLSchema#string

P921

P932

3491858

http://www.w3.org/2001/XMLSchema#string